Oramed Pharmaceuticals (ORMP) Change in Cash (2010 - 2026)
Oramed Pharmaceuticals' (ORMP) quarterly Change in Cash came in at -$32.7 million in Q1 2026, down 262.94% YoY from $20.1 million in Q1 2025, and down 425.43% on a QoQ basis from -$6.2 million in Q4 2025.
Oramed Pharmaceuticals (ORMP) Change in Cash (2010 - 2026) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 17 years of Change in Cash data on file, last reported at -$32.7 million in Q1 2026.
- Quarterly Change in Cash fell 262.94% year-over-year to -$32.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$61.3 million (down 209.61% YoY) and the FY2025 annual result came in at -$8.5 million, down 118.68% from the prior year.
- Change in Cash eased to -$32.7 million in Q1 2026, from -$6.2 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $66.2 million in Q2 2024 to a low of -$58.7 million in Q2 2025.
- A 5-year average of -$838470.6 and a median of $1.9 million in 2022 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2023 — Change in Cash slumped 3301.57% — and 2024, when it soared 481.71%.
- Tracing ORMP's Change in Cash over 5 years: stood at $7.3 million in 2022, then slumped by 50.65% to $3.6 million in 2023, then jumped by 243.35% to $12.3 million in 2024, then slumped by 150.6% to -$6.2 million in 2025, then sank by 425.43% to -$32.7 million in 2026.
- The last three Change in Cash figures came in at -$32.7 million (Q1 2026), -$6.2 million (Q4 2025), and $36.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - | 2.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.04 Mn |
| Mar 31, 2026 | -32.75 Mn |
| Dec 31, 2025 | -6.23 Mn |
| Sep 30, 2025 | 36.38 Mn |
| Jun 30, 2025 | -58.72 Mn |
| Mar 31, 2025 | 20.10 Mn |
| Dec 31, 2024 | 12.32 Mn |
| Sep 30, 2024 | -42.65 Mn |
| Jun 30, 2024 | 66.18 Mn |
| Mar 31, 2024 | 9.52 Mn |
| Dec 31, 2023 | 3.59 Mn |
| Sep 30, 2023 | -1.30 Mn |
| Jun 30, 2023 | -17.34 Mn |
| Mar 31, 2023 | -16.36 Mn |
| Dec 31, 2022 | 7.27 Mn |
| Sep 30, 2022 | 3.30 Mn |
| Jun 30, 2022 | 1.93 Mn |
| Mar 31, 2022 | 511,000.00 |
| Nov 30, 2021 | -45.37 Mn |
| Aug 31, 2021 | 51.97 Mn |